ity and resistance to synergism and attempted to delineate the biochemical mechanism of this resistance.
Materials and Methods
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The organisms used in this study were isolated from clinical specimens submitted to the microbiology laboratory of Hermann Hospital (Houston) during the period of March-October 1981. All organisms were presumptively identified as enterococci using bile esculin agar and growth in the presence of 6.5% NaCI and were subsequently confirmed biochemically as enterococci in our laboratory. Those organisms showing high-level resistance to any aminoglycoside were serologically grouped using the Phadebact'P (Pharmacia Diagnostics, Piscataway, N.J.) slide agglutination technique. Selected strains were further tested for fermentation of sorbitol and arabinose, as well as by the API (Analytical Profile Index)-20S system (Analytical Products, Plainview, N.Y.) to differentiate species of group D enterococci. When multiple positive cultures from the same patient were submitted, only a single enterococcal isolate from anyone source was used for this study. All organisms were screened for {3-hemolysis using trypticase soy agar (Difco Laboratories, Detroit) with 5OJo horse blood.
Susceptibility testing. All organisms were screened for high-level resistance to gentamicin (Schering Corp., Bloomfield, N.J.), tobramycin, streptomycin (both from Eli Lilly and Co., Indianapolis), and kanamycin (Bristol Laboratories, Syracuse, N.Y.) using an inoculum-replicating device to inoculate undiluted overnight cultures onto brain-heart infusion agar (Difco). Isolates were defined as having high-level resistance if growth was visible on plates containing 2,000 ug of a given aminoglycoside/ml.
MICs of gentamicin, tobramycin, streptomycin, kanamycin, and amikacin (Bristol) were determined for randomly chosen strains by the agardilution technique [8] using dextrose phosphate broth (Difco) containing 0.80/0 agar and serial twofold dilutions of antibiotic. An inoculumreplicating device was used to inoculate undiluted overnight cultures in dextrose phosphate broth onto the agar surface. Staphylococcus aureus strain ATCC 25923 and enterococcal recipient strain JH2-7 [9, 10] were used as controls. In addition, MICs were further determined by broth dilution for selected strains exhibiting high-level resistance. Serial twofold dilutions of four aminoglycosides were used, and the inoculum consisted of "-110 6 cfu/ml diluted from an overnight culture. The MIC was defined as the lowest concentration of antibiotic that prevented visible growth after incubation for 18-24 hr.
Transfer of antibiotic resistance. Filter matings were performed with enterococcal strain JH2-7 (thy-, Rif", Fus r ) as the susceptible recipient [9, 10] . Samples of donor and recipient overnight cultures were mixed in a 1:10 ratio in 4.5 ml of brain-heart infusion broth and filtered (pore size, 0.45 urn; Millipore Corp., Bedford, Mass.); the filter was placed on top of brain-heart infusion agar [11] . After overnight incubation at 37 C, the cells were dispersed in 1 ml of 0.90/0 NaCI, and O.l-ml volumes of these suspensions were spread onto brain-heart infusion agar plates containing rifampin (100 ug/rnl: Calbiochem-Behring, La Jolla, Calif.) and gentamicin (1,000 ug/rnl). After overnight incubation, transconjugants were restreaked for isolation of single colonies on the same medium, and single colonies were tested for all resistance markers as well as fJ-hemolysis on 50/0 horse blood agar using an inoculum-replicating device.
Synergy studies. Synergism experiments were performed according to the protocol of Moellering et al. [4] . Penicillin (E. R. Squibb and Son, Princeton, N.J.) was used at 10 units/ml for all donors except strain HH-22, for which a higher concentration was required, and strain JH2-7 and the transconjugants, for which four units/ml was used. Aminoglycoside concentrations were chosen to reflect clinically achievable concentrations and were less than the MICs for these enterococci. Synergism was defined as a~2 log increase in killing at 24 hr by the combination of both drugs as compared with penicillin alone, when the aminoglycosides were present in subinhibitory concentrations.
Enzyme assays. Streptococcal extracts were prepared as described [11] . Enzyme assays were performed according to the phosphocellulose paper binding protocol of Benveniste and Davies [12] with the following modifications. The total reaction mixture volume, consisting of radioactive substrate, buffer, and enzyme, was 40 J,ll, with the final concentrations of aminoglycoside substrate ranging from 100 to 250 J,lg/ml for the phosphotransferase and acetyltransferase assays and from 10 to 1,000 J,lg/ml for the adenylyltransferase assay. Enzyme mixtures were incubated at 37 C for 1 hr, and specific enzyme activities were quantitated relative to substrate standards.
The isotopes [y_32P] adenosine triphosphate (3,100 Ci/mmol), [1-14C] 
Results
Susceptibility testing. Table 1 shows the prevalence of high-level resistance to gentamicin, tobramycin, streptomycin, and kanamycin among the 200 enterococcal isolates tested, according to their site of isolation. Resistance to streptomycin and kanamycin occurred most frequently (270/0 of strains) and was seen most commonly among urine isolates. Of the 57 isolates showing highlevel resistance to one or more of the aminoglyco- NOTE. High-level resistance was defined as an MIC of >2,000 ,.,g/ml.
• These nine strains were also highly resistant to tobramycin, streptomycin, and kanamycin. Figure 1 . Susceptibilities of 147 clinical isolates of enterococci to five aminoglycosidic aminocyclitols, as determined by the agar dilution method [8] .
16 32 64 128 256 512 1024 2048 AMINOGLYCOSIOE CONCENTRATION ug/ml 05 tobramycin along with resistance to gentamicin; two strains did not transfer resistance to streptomycin. The MICs of streptomycin, gentamicin, kanamycin, and amikacin for a transconjugant of one of these latter strains, XH-22, were 128, 64,000, 64,000, and 4,000 IAg/ml, respectively. None of the three donors that were fJ-hemolytic cotransferred this property with resistance to gentamicin to the recipient strain. sides tested, the most common pattern was resistance to streptomycin plus kanamycin (42 strains). High-level resistance to gentamicin occurred in nine strains and was always associated with resistance to tobramycin, kanamycin, and streptomycin. High-level resistance to kanamycin only or to streptomycin only was observed infrequently (three strains each). One hundred forty-seven isolates, including the nine gentamicin-resistant strains, were tested by agar dilution for susceptibility to five aminoglycosides (figure I). Gentamicin and tobramycin were more active on a weight basis than amikacin, kanamycin, or streptomycin. About 90070 of strains were inhibited by~1281Ag of gentamicin or tobramycin/ml as compared with 1,024 lAg of amikacin/ml, whereas 70070 of strains were inhibited by~512 lAg of streptomycin or kanamycin/ml. In addition, broth dilution MICs of four aminoglycosides were determined for three gentamicin-resistant strains (table 2) .
All 57 organisms showing high-level resistance to any aminoglycoside were serologically confirmed to be group D streptococci. The nine gentamicin-resistant strains were further identified as Streptococcus faecalis by sugar fermentation reactions [13] and API-20S biochemical tests. fJ-Hemolysis on 5% horse blood agar was produced by three of these multiply resistant strains.
Mating experiments. Eight of the nine strains highly resistant to gentamicin were chosen for transfer studies. In all instances, growth was almost confluent on the doubly selective medium; the mating frequency determined for one of these strains was 6.7 x 10-4 transconjugants per recipient. Six of the eight strains cotransferred highlevel resistance to streptomycin, kanamycin, and Synergy studies. Three of our highly gentamicin-resistant strains were used in synergy experiments using penicillin in combination with tobramycin, gentamicin, streptomycin, or kanamycin. All combinations failed to show synergism. With strain HH-22, kanamycin appeared to antagonize the effect of penicillin. The transconjugants of two of these strains also failed to show synergism with any of the penicillin-aminoglycoside combinations; the results with the recipient (JH2-7) and one transconjugant (XH-54) are shown in figure 2. Strain XH-22 was not highly resistant to streptomycin and remained susceptible to penicillin-streptomycin synergism. One donor strain, HH-54, was selected for further testing with ampicillin or vancomycin plus gentamicin, netilmicin, or amikacin. Again, none of these combinations was synergistic against strain HH-54.
Enzyme assays. Aminoglycoside-modifying enzymes were detected in each of three gentamicinresistant clinical isolates tested (HH-22, HH-54, and HH-67) and in their transconjugants. Phosphotransferase activity was present in all of these donor strains and appeared to be both a 3'-and a 2"-phosphotransferase. Substrate profiles of phosphorylating activity are shown for two donors and their transconjugants in table 3. The kanamycins and neomycin, all of which possess a 3'-hydroxyl group, were strongly phosphorylated, unlike tobramycin (3'-deoxykanamycin B), which is structurally similar but lacks this group. The fact that the gentamicins, sisomicin, and netilmicin were NOTE. NT = not tested.
* Percentage activity relative to kanamycin A after incubation for I hr at 37 C and pH 7.1, using 100 lAg of antibiotic substrate/ml. For strains HH-22, HH-54, XH-22, and XH-54, the respective amounts of label incorporated were 33,777, 47,231, 6,036, and 36,118 cpm.
t Percentage activity relative to gentamicin CIa after incubation for I hr at 37 C and pH 5.8, using 250 I1g of antibiotic substrate/ ml. For strains HH-22 and XH-22, the respective amounts of label incorporated were 714 and 2,300 cpm.
also substrates for phosphorylation but 2"-deoxysisomicin was not indicates that the 2"-hydroxyl group was another site at which phosphorylation was occurring. Lividomycin A was phosphorylated as efficiently as the kanamycin derivatives. Two of the three transconjugants, XH-54 and XH-67, acquired both 3'-and 2"-phosphotransferase activity from the donor strains. With one transconjugant, XH-22, 2"-but not 3'-phosphorylation activity was present (table 3) : neomycin, lividomycin A, and ribostamycin (which were good substrates with the donor enzyme preparation) were poorly phosphorylated with the enzyme from this transconjugant. Acetyltransferase activity was also detected in the three donor strains and their transconjugants. Substrate profiles for a representative donor and its transconjugant are shown in table 3. Kanamycin A and B, gentamicin B, neomycin, ribostamycin, and gentamicin CIa were excellent substrates for acetylation, in contrast to structurally similar kanamycin C or gentamicin Cl, which lack or are blocked at the 6'-amino group. At antibiotic concentrations of 100 I-lg/ml, relatively poor acetylation of gentamicin CIa, sisomicin, and neomycin was noted, whereas at 250 ug/ml, activity was much more readily detectable. The kanamycins were equally well acetylated at all concentrations, and acetylation of ribostamycin (data not shown) decreased at higher concentrations. Netilmicin was a weak substrate at both concentrations. These results suggest that the 6'-amino group is the site of acetylation in both donor and transconjugant strains.
Streptomycin adenylyltransferase activity was optimally detected in all three donors and the two streptomycin-resistant transconjugants, XH-54 and XH-67, using a final antibiotic concentration of 25 ug/ml. No adenylyltransferase activity was seen with spectinomycin, gentamicin, or kanamycin.
Discussion
Our results indicate that enterococci highly resistant to all clinically available aminoglycoside aminocyclitols have now emerged in the United States. These strains are also, as would be predicted, resistant to combinations of penicillin plus an aminoglycoside. The nine highly gentamicin-resistant strains described here were obtained from clinically significant sites of infection, although none was a blood isolate. In only three cases was it known that antibiotic therapy at the time of isolation of the organism included an aminoglycoside. Information regarding follow-up of therapy or outcome of infection was not available for this study. The predominance of urine and wound isolates showing high-level aminoglycoside resistance is in keeping with the results of other studies of enterococcal resistance [3, 14] performed over the past decade. However, we did observe considerably less high-level resistance to streptomycin and kanamycin in wound and blood isolates than was previously reported [3, 14] . This finding may be a reflection of the decreased use of these aminoglycos ides over the past 10-15 years. Of particular interest is the finding that all of the gentamicin-resistant strains were also highly resistant to tobramycin, streptomycin, kanamycin, and amikacin.
The MICs of amikacin (4,000 ug/ml) for three of these gentamicin-resistant strains are the highest reported in the literature for enterococci and may be a reflection of the presence of several enzyme activities modifying this substrate in an additive fashion. These strains differ from the gentamicinresistant isolates from France [6] , all of which were S. faecalis subspecies zymogenes (J3-hemolytic) and were not highly resistant to streptomycin.
The eight strains tested for transfer of gentamicin resistance revealed a high transfer frequency for this marker, and of these strains, six cotransferred resistance to the three remaining aminoglycosides in 100070 of transconjugants analyzed. These findings suggest that the high-level aminoglycoside resistance in these enterococci is mediated by a conjugative plasmid(s) which transfers (or mobilizes) these resistances simultaneously at a high frequency.
Considering the extent of aminoglycoside resistance demonstrated by our strains, it was not unexpected that several varied aminoglycosidemodifying enzymes were detected. The presence of a 3/-phosphotransferase was inferred from the marked phosphorylating activity demonstrated with aminoglycosides possessing a 3/-hydroxyl group (the kanamycins, neomycin, and amikacin) and the relative lack of activity with tobramycin.
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Because lividomycin A, butirosin, and ribostamycin were excellent substrates and amikacin was also a substrate, it is most likely that the enzyme is a 3/-phosphotransferase type III, which is consistent with the finding of others [15, 16] . This enzyme was present in the three clinical isolates examined and transferred to strain JH2-7 from two of the three. A 2"-phosphotransferase modifying, among others, gentamicin, tobramycin, and amikacin, explains in part the mechanism of highlevel resistance to gentamicin and tobramycin; this enzyme was present in the three donors and the three transconjugants tested. The high percentage activity of transconjugant XH-22 (which lacks 3/-phosphotransferase) against amikacin and netilmicin may be due to the long incubation time we used; it is similar to the activity previously reported with 2"-phosphotransferase [17] . A 6/-acetyltransferase detected in all three donors and their transconjugants may also help explain the high-level resistance to gentamicin and tobramycin. Although detected using lower concentrations of substrate, acetylation of gentamicin Cia was significantly enhanced with higher concentrations, as was the activity with sisomicin and neomycin (principally neomycin B). Netilmicin and butirosin were consistently weak substrates for this enzyme activity at the various concentrations tested. 2"-Phosphotransferase and 6'-acetyltransferase activities were also found in the gentamicin-resistant enterococcal strain BM41 00 (D362) isolated in France, similar to those found in S. aureus [6, 17] .
We also detected a streptomycin adenylyltransferase in the three donors and in both of the transconjugants exhibiting high-level streptomycin resistance. Because this enzyme was not active against spectinomycin, it is most likely that adenylylation is taking place at position 6 on the streptidine ring rather than at the 3"-hydroxyl position of the glucosamine moiety as is seen with gramnegative bacteria [15, 16] . A similar adenylyltransferase and 3/-phosphotransferase have been reported in enterococci with high-level resistance to streptomycin and kanamycin [15] . The various enzymes in our strains appear to be produced constitutively because they, and the high-level resistance, were present in bacteria passaged several times in the absence of antibiotic.
In conclusion, we have described nine clinical isolates of S. faecalis highly resistant to all of the aminoglycosides clinically available in U.S. hospitals. This resistance may be related, at least in part, to the selective pressure resulting from the extensive use of aminoglycosides in these hospitals. The finding of multiple aminoglycosidemodifying enzymes coexisting in the same strains explains the high-level resistance and resistance to synergism seen with these isolates. Although none of our highly gentamicin-resistant strains was a blood isolate, the genitourinary tract and wounds remain among the most common sources of enterococci causing bacteremia. The clinical implications of developing endocarditis caused by such resistant organisms are grave, and we can no longer feel confident that the combination of penicillin plus gentamicin will be effective either therapeutically or prophylactically. Screening for highlevel resistance to gentamicin as well as to other aminoglycosides should thus be performed routinely for all blood isolates of enterococci.
